Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-08
2006-08-08
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S229000, C548S231000
Reexamination Certificate
active
07087629
ABSTRACT:
Compounds of formula (I)or a pharmaceutically-acceptable salt, or an in-vivo-hydrolysable ester thereof, wherein, for example, HET is an optionally substituted C-linked 5-membered heteroaryl ring containing 2 to 4 heteroatoms independently selected from N, O and S; Q is selected from, for example, Q3 and Q5; R2and R3are independently hydrogen or fluoro; T is selected from a range of groups, for example, an N-linked (fully unsaturated) 5-membered heteroaryl ring system or a group of formula (TC5): wherein Rc is, for example, R13CO—, R13SO2— or R13CS—; wherein R13is, for example, optionally substituted (1–10C)alkyl or R14C(O)O(1–6C)alkyl wherein R14is optionally substituted (1–10C)alkyl; are useful as antibacterial agents; and processes for their manufacture and pharmaceutical compositions containing them are described.
REFERENCES:
patent: 4705799 (1987-11-01), Gregory
patent: 5792765 (1998-08-01), Riedl et al.
patent: 6734200 (2004-05-01), Gravestock
patent: 0 127 902 (1984-12-01), None
Chemical Abstract; vol. 122, 55826, No. 5, 1995.
Chemical Abstract, vol. 124; 342951, No. 25, 1996.
Society of Toxicologists Annual Meeting, 1996, Abstract No. 564.
M.R. Barcachyn et al., Bioorganic & Med. Chem. Letters, 1996, vol. 6, No. pp. 1009-1014.
D.L. Shinabarger et al, Antimicrobial Agents Chemotehr., 1997, Vo. 41, No. 10, pp. 2132-2136.
D.C. Eustice, J. Antimicrob. Chemother., 1988, Vo. 32, No. 8, pp. 1218-1222.
J.S. Daley et al., J. Antimicrob. Chemother., 1988, vol. 21, No. 6, pp. 721-730.
Interscience Congress of Antimicrobial Agents and Chemotherapy conference abstracts: Sep. 17-20, 1995, Upjohn Oxazolidinone Antibacterial agents.
Interscience Congress of Antimicrobial Agents and Chemotherapy conference abstracts: Sep. 15-18, 1996, 899, C42, F231, F233, F234, C101, F232.
Interscience Congress of Antimicrobial Agents and Chemotherapy conference abstracts: Sep. 28-Oct. 1, 1997, C101, C102, F17-F28.
AstraZeneca AB
Stockton Laura L.
LandOfFree
Heterocyclylaminomethyloxazolidinones as antibacterials does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclylaminomethyloxazolidinones as antibacterials, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclylaminomethyloxazolidinones as antibacterials will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3701291